PHARMACEUTICAL RDI & INVESTMENTS

Promoteur – Intermédiaire Financier

GALENICUM HEALTH SL

Lieu

• Espagne

Description

The project will finance the promoter's pharmaceutical RDI and expansion investments in Spain.

Objectifs

The EIB loan will be used to support the implementation of the company's strategy. The investments are expected to support the promoter's competitiveness and growth.

Secteur(s)

• Industrie - Industrie manufacturière

Montant BEI envisagé (montant approximatif)

EUR 20 million

Coût total (montant approximatif)

EUR 50 million

Aspects environnementaux

All aspects related to the environmental impact and permits will be verified during the project's appraisal.

Passation des marchés

The promoter has been assessed by the EIB as being a private company not operating in the utilities sector and not having a status of a contracting entity, thus not being subject to EU rule on public procurement.

Statut

Signé - 14/01/2021